Immediate Impact

1 by Nobel laureates 26 from Science/Nature 66 standout
Sub-graph 1 of 23

Citing Papers

Efficacy and Safety of an Ad26.RSV.preF–RSV preF Protein Vaccine in Older Adults
2023 Standout
Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults
2023 Standout
1 intermediate paper

Works of Clement Asiedu being referenced

Recombinant Adenovirus Serotype 26 (Ad26) and Ad35 Vaccine Vectors Bypass Immunity to Ad5 and Protect Nonhuman Primates against Ebolavirus Challenge
2011

Author Peers

Author Last Decade Papers Cites
Clement Asiedu 183 399 198 14 641
Jerome Custers 231 308 155 13 600
Emily Burke 149 326 236 17 679
Kirsten Kabsch 133 300 300 9 607
Aaron E. Lin 375 289 127 17 729
Julia E. Biggins 130 475 178 17 703
Nathalie Alazard-Dany 286 307 184 13 676
Anna Bruchez 100 501 203 8 670
Colette Pietzsch 172 386 142 22 590
Rhys Pryce 133 499 139 11 670
Harald Bugany 70 440 159 12 590

All Works

Loading papers...

Rankless by CCL
2026